These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 38767023)

  • 1. Polygenic Risk Scores Validated in Patient-Derived Cells Stratify for Mitochondrial Subtypes of Parkinson's Disease.
    Arena G; Landoulsi Z; Grossmann D; Payne T; Vitali A; Delcambre S; Baron A; Antony P; Boussaad I; Bobbili DR; Sreelatha AAK; Pavelka L; J Diederich N; Klein C; Seibler P; Glaab E; Foltynie T; Bandmann O; Sharma M; Krüger R; May P; Grünewald A;
    Ann Neurol; 2024 Jul; 96(1):133-149. PubMed ID: 38767023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validity and Prognostic Value of a Polygenic Risk Score for Parkinson's Disease.
    Koch S; Laabs BH; Kasten M; Vollstedt EJ; Becktepe J; Brüggemann N; Franke A; Krämer UM; Kuhlenbäumer G; Lieb W; Mollenhauer B; Neis M; Trenkwalder C; Schäffer E; Usnich T; Wittig M; Klein C; König IR; Lohmann K; Krawczak M; Caliebe A
    Genes (Basel); 2021 Nov; 12(12):. PubMed ID: 34946808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-Wide Polygenic Score Predicts Large Number of High Risk Individuals in Monogenic Undiagnosed Young Onset Parkinson's Disease Patients from India.
    Kukkle PL; Geetha TS; Chaudhary R; Sathirapongsasuti JF; Goyal V; Kandadai RM; Kumar H; Borgohain R; Mukherjee A; Oliver M; Sunil M; Mootor MFE; Kapil S; Mandloi N; Wadia PM; Yadav R; Desai S; Kumar N; Biswas A; Pal PK; Muthane UB; Das SK; Sakthivel Murugan SM; Peterson AS; Stawiski EW; Seshagiri S; Gupta R; Ramprasad VL; Prai PRAOI
    Adv Biol (Weinh); 2022 Nov; 6(11):e2101326. PubMed ID: 35810474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of the Polygenic Risk Score with the Incidence Risk of Parkinson's Disease and Cerebrospinal Fluid α-Synuclein in a Chinese Cohort.
    Li WW; Fan DY; Shen YY; Zhou FY; Chen Y; Wang YR; Yang H; Mei J; Li L; Xu ZQ; Wang YJ
    Neurotox Res; 2019 Oct; 36(3):515-522. PubMed ID: 31209785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial and autophagy-lysosomal pathway polygenic risk scores predict Parkinson's disease.
    Dehestani M; Liu H; Sreelatha AAK; Schulte C; Bansal V; Gasser T
    Mol Cell Neurosci; 2022 Jul; 121():103751. PubMed ID: 35710056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of Parkinson's Disease Risk Based on Genetic Profile and Established Risk Factors.
    Chairta PP; Hadjisavvas A; Georgiou AN; Loizidou MA; Yiangou K; Demetriou CA; Christou YP; Pantziaris M; Michailidou K; Zamba-Papanicolaou E
    Genes (Basel); 2021 Aug; 12(8):. PubMed ID: 34440451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of low-pass genome sequencing in polygenic risk score calculation for Parkinson's disease.
    Kim S; Shin JY; Kwon NJ; Kim CU; Kim C; Lee CS; Seo JS
    Hum Genomics; 2021 Aug; 15(1):58. PubMed ID: 34454617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rare genetic variation in mitochondrial pathways influences the risk for Parkinson's disease.
    Gaare JJ; Nido GS; Sztromwasser P; Knappskog PM; Dahl O; Lund-Johansen M; Maple-Grødem J; Alves G; Tysnes OB; Johansson S; Haugarvoll K; Tzoulis C
    Mov Disord; 2018 Oct; 33(10):1591-1600. PubMed ID: 30256453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immortalized Parkinson's disease lymphocytes have enhanced mitochondrial respiratory activity.
    Annesley SJ; Lay ST; De Piazza SW; Sanislav O; Hammersley E; Allan CY; Francione LM; Bui MQ; Chen ZP; Ngoei KR; Tassone F; Kemp BE; Storey E; Evans A; Loesch DZ; Fisher PR
    Dis Model Mech; 2016 Nov; 9(11):1295-1305. PubMed ID: 27638668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is age-related failure of metabolic reprogramming a principal mediator in idiopathic Parkinson's disease? Implications for treatment and inverse cancer risk.
    Engel PA
    Med Hypotheses; 2016 Aug; 93():154-60. PubMed ID: 27372878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of polygenic risk score with response to deep brain stimulation in Parkinson's disease.
    Yoon E; Ahmed S; Li R; Bandres-Ciga S; Blauwendraat C; Dustin I; Scholz S; Hallett M; Ehrlich D
    BMC Neurol; 2023 Apr; 23(1):143. PubMed ID: 37016359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Large-scale pathway specific polygenic risk and transcriptomic community network analysis identifies novel functional pathways in Parkinson disease.
    Bandres-Ciga S; Saez-Atienzar S; Kim JJ; Makarious MB; Faghri F; Diez-Fairen M; Iwaki H; Leonard H; Botia J; Ryten M; Hernandez D; Gibbs JR; Ding J; Gan-Or Z; Noyce A; Pihlstrom L; Torkamani A; Soltis AR; Dalgard CL; ; Scholz SW; Traynor BJ; Ehrlich D; Scherzer CR; Bookman M; Cookson M; Blauwendraat C; Nalls MA; Singleton AB;
    Acta Neuropathol; 2020 Sep; 140(3):341-358. PubMed ID: 32601912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered Transcriptional Profile of Mitochondrial DNA-Encoded OXPHOS Subunits, Mitochondria Quality Control Genes, and Intracellular ATP Levels in Blood Samples of Patients with Parkinson's Disease.
    Gezen-Ak D; Alaylıoğlu M; Genç G; Şengül B; Keskin E; Sordu P; Güleç ZEK; Apaydın H; Bayram-Gürel Ç; Ulutin T; Yılmazer S; Ertan S; Dursun E
    J Alzheimers Dis; 2020; 74(1):287-307. PubMed ID: 32007957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Additional rare variant analysis in Parkinson's disease cases with and without known pathogenic mutations: evidence for oligogenic inheritance.
    Lubbe SJ; Escott-Price V; Gibbs JR; Nalls MA; Bras J; Price TR; Nicolas A; Jansen IE; Mok KY; Pittman AM; Tomkins JE; Lewis PA; Noyce AJ; Lesage S; Sharma M; Schiff ER; Levine AP; Brice A; Gasser T; Hardy J; Heutink P; Wood NW; Singleton AB; Williams NM; Morris HR;
    Hum Mol Genet; 2016 Dec; 25(24):5483-5489. PubMed ID: 27798102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibroblast mitochondria in idiopathic Parkinson's disease display morphological changes and enhanced resistance to depolarization.
    Antony PMA; Kondratyeva O; Mommaerts K; Ostaszewski M; Sokolowska K; Baumuratov AS; Longhino L; Poulain JF; Grossmann D; Balling R; Krüger R; Diederich NJ
    Sci Rep; 2020 Jan; 10(1):1569. PubMed ID: 32005875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial oxidative phosphorylation defects in Parkinson's disease.
    Shoffner JM; Watts RL; Juncos JL; Torroni A; Wallace DC
    Ann Neurol; 1991 Sep; 30(3):332-9. PubMed ID: 1952821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical profiles of Parkinson's disease associated with common leucine-rich repeat kinase 2 and glucocerebrosidase genetic variants in Chinese individuals.
    Wang C; Cai Y; Gu Z; Ma J; Zheng Z; Tang BS; Xu Y; Zhou Y; Feng T; Wang T; Chen SD; Chan P;
    Neurobiol Aging; 2014 Mar; 35(3):725.e1-6. PubMed ID: 24095219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parkinson's disease polygenic risk score is not associated with impulse control disorders: A longitudinal study.
    Ihle J; Artaud F; Bekadar S; Mangone G; Sambin S; Mariani LL; Bertrand H; Rascol O; Durif F; Derkinderen P; Scherzer C; Elbaz A; Corvol JC; ; ; ; ; ; ; ;
    Parkinsonism Relat Disord; 2020 Jun; 75():30-33. PubMed ID: 32450545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polygenic load: Earlier disease onset but similar longitudinal progression in Parkinson's disease.
    Lerche S; Liepelt-Scarfone I; Wurster I; Schulte C; Schäffer E; Röben B; Machetanz G; Zimmermann M; Akbas S; Hauser AK; Gasser T; Maetzler W; Berg D; Brockmann K
    Mov Disord; 2018 Aug; 33(8):1349-1353. PubMed ID: 30132985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular history and risk of idiopathic Parkinson's disease: a cross-sectional observational study.
    Acharya S; Lumley AI; Devaux Y;
    BMC Neurosci; 2024 Jul; 25(1):33. PubMed ID: 38977971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.